Target intelligence / Profile preview

NAXE pseudogene 2 (NAXEP2)

Target
NAXEP2
Molecular classification
Pseudogene
01

Overview

NAXE pseudogene 2 (NAXEP2) is a processed pseudogene, meaning it is derived from the retrotransposition of mRNA, and thus lacks introns and canonical promoter/enhancer sequences. As a pseudogene, it shares sequence similarity with the parent gene coding for NAD(P)HX epimerase, possibly the functional gene NAXE (previously named AIBP), but does not produce a functional protein. Pseudogenes like NAXEP2 are generally considered non-coding relics, although some may have regulatory activity through RNA-based mechanisms or impact gene expression in disease contexts. Current literature and public databases do not provide evidence for NAXEP2 having direct biological, therapeutic, or disease-related roles.

Other names
NAD(P)HX epimerase pseudogeneApolipoprotein A-I binding protein pseudogeneNAXEP2
02

Mechanism of action

Not applicable.

03

Biological functions

No known direct protein-coding function; pseudogenes typically do not encode functional proteins.Some pseudogenes may influence gene regulation at the RNA level, but no functional data specific to NAXEP2 is currently available.
04

Disease associations

No specific disease role assigned for NAXEP2. Generally, certain pseudogenes have been implicated as regulators, biomarkers, or modulators in various diseases (notably cancer), but such roles are not attributed specifically to NAXEP2 in available literature.
05

Safety considerations

None known.
06

Interacting drugs

None known. There are no known drugs that interact with NAXEP2, as it is not a functional protein or a validated therapeutic target.
07

Biomarkers

Not established.

Beyond the preview

Go deeper on NAXE pseudogene 2 (NAXEP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NAXE pseudogene 2 (NAXEP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call